A nanobody-based complement inhibitor targeting complement component 2 reduces hemolysis in a complement humanized mouse model of autoimmune hemolytic anemia.
A nanobody-based complement inhibitor targeting complement component 2 reduces hemolysis in a complement humanized mouse model of autoimmune hemolytic anemia.
复制标题
DOI：
10.1016/j.clim.2023.109678
复制
发表时间：
2023-06
影响因子：
8.6
通讯作者：
Jin Y Chen;Lingjun Zhang;L. Luo;Maojing Yang;Yinghua Chen;F. Lin
中科院分区：
文献类型：
--
作者：
Jin Y Chen;Lingjun Zhang;L. Luo;Maojing Yang;Yinghua Chen;F. Lin
